GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Sommer, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- Ucla Health
Los Angeles, California, United States
- Santa Barbara Cottage Hospital Research Institute
Santa Barbara, California, United States
- South Denver Cardiology
Denver, Colorado, United States
- Medical Center of the Rockies
Loveland, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Mercy One Iowa Heart Center
West Des Moines, Iowa, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Hospital
Ann Arbor, Michigan, United States
- University at Buffalo
Buffalo, New York, United States
- Sjh Cardiology Associates
Liverpool, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Aurora St Luke'S Medical Center
Milwaukee, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Feb 2021
- Primary completion
- 15 Aug 2024
- Completion
- 15 Aug 2024
- Last update posted
- 9 Jun 2026
- Registered enrollment
- 7
- Registry id
- NCT04100135
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.